Nobuhiro Hiramoto

Chief physician

Kobe University Hospital

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Nobuhiro Hiramoto is a Chief Physician at Kobe City Medical Center General Hospital in Japan. His research focuses on hematological malignancies, transplantation outcomes, and the effects of viral infections in immunocompromised patients. Recent publications include studies on HHV-6 encephalitis, SARS-CoV-2 RNA load in hematological patients, and the safety of COVID-19 vaccines in transplant recipients.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Takaaki Konuma

University of Tokyo

JAPAN

View details

Yotaro Ochi

Kyoto University

JAPAN

View details

Seishi Ogawa

Kyoto University

JAPAN

View details

Masataka Taguchi

Assistant professor

Nagasaki University

JAPAN

View details

Akiyoshi Takami

Professor

Aichi Medical University

JAPAN

View details

Kazuhito Suzuki

The Jikei University Hospital

JAPAN

View details

Masashi Nishikubo

Kobe University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nobuhiro Hiramoto

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Post-azacitidine clone size predicts outcome of patients with myelodysplastic syndromes and related myeloid neoplasms.

Trajectories of the SARS‐CoV‐2 RNA load in patients with hematological malignancy

Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in allogeneic hematopoietic stem cell transplant recipients: An observational study

Cerebrospinal fluid concentration of foscarnet in patients with HHV-6 encephalitis after haematopoietic stem cell transplantation.

Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis.

Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia

Favorable Outcome with Conditioning Regimen of Flu/Bu4/Mel in Acute Myeloid Leukemia Patients in Remission Undergoing Cord Blood Transplantation.

Haploidentical transplantation with post‐transplant cyclophosphamide versus single cord blood transplantation for myelodysplastic syndrome: A retrospective study from the Adult Myelodysplastic Syndrome Working Group of the Japanese Society for Transplantation and Cellular Therapy (JSTCT)

Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors.

Adenovirus disease after hematopoietic cell transplantation: A Japanese transplant registry analysis.

Collaborators (7)

Takaaki Konuma

Yotaro Ochi

Seishi Ogawa

Masataka Taguchi

Akiyoshi Takami

Kazuhito Suzuki

Masashi Nishikubo

Make your next move.